Intraoperative Hypotension and Postoperative Organ Injury: What the Threshold Evidence Shows
A synthesis of large cohort studies, meta-analyses of RCTs, and the 2024 POQI consensus statement defining the MAP thresholds, durations, and dose-response relationships linking intraoperative hypotension to acute kidney injury, myocardial injury, stroke, and mortality.
This is an original evidence synthesis. See References for source studies.
One-Minute Takeaway
One-Minute Takeaway
- Intraoperative hypotension and organ injury thresholds converge around MAP 65 mmHg: below this level, risk of acute kidney injury and myocardial injury increases in a dose-dependent fashion with both depth and duration of exposure (Salmasi et al. 2017, n = 57,315).
- The harm relationship is graded: prolonged exposure (≥10 min) to MAP <80 mmHg, shorter durations at MAP <70 mmHg, and any exposure to MAP <55 mmHg are each associated with postoperative organ injury across multiple observational studies.
- The 2024 POQI international consensus recommends maintaining MAP ≥60 mmHg in at-risk patients during surgery — yet RCTs comparing higher versus lower MAP targets have not demonstrated that targeting MAP ≥75 mmHg reduces complications versus ≥60 mmHg.
- Baseline patient risk modifies the hypotension-injury relationship: low-risk patients show no association between mild hypotension and AKI, whereas high-risk patients develop injury even at MAP 55–59 mmHg (Mathis et al. 2020, n = 138,021).
- Postoperative hypotension may be more strongly associated with myocardial infarction and death than intraoperative hypotension, yet it remains under-monitored and under-studied.
Why This Topic Matters
Intraoperative hypotension is extraordinarily common. Defined as MAP below 65 mmHg, it occurs in approximately 65% of all surgical procedures. Using a more permissive definition of 20% reduction from baseline, the incidence approaches 94%. Despite this ubiquity, over 100 different definitions of intraoperative hypotension appear in the literature, complicating both research and clinical practice. The stakes are high: postoperative organ injury — particularly acute kidney injury, myocardial injury, and stroke — substantially increases morbidity, mortality, and healthcare costs.
The clinical question has evolved from “is intraoperative hypotension harmful?” (now well established) to “at what threshold, for how long, and in which patients does harm begin?” This review synthesises the threshold evidence — the depth-duration-risk relationships that define the boundaries of safe intraoperative blood pressure management — and examines whether interventional trials have confirmed that avoiding hypotension improves outcomes.
What Evidence Was Reviewed
This synthesis draws on large retrospective cohort studies that established the dose-response relationship between intraoperative hypotension and organ injury, systematic reviews, meta-analyses of RCTs comparing different blood pressure targets, the POISE-2 substudy, and the 2024 POQI international consensus statement. The evidence is overwhelmingly from noncardiac surgery in adults.
| Study | Design | n | Population | Key Finding | Quality |
|---|---|---|---|---|---|
| Salmasi et al. 2017 | Retrospective cohort | 57,315 | Noncardiac surgery | MAP <65 mmHg or >20% below baseline progressively associated with AKI + myocardial injury; ≥13 min cumulative exposure increased risk | Moderate |
| Walsh et al. 2013 | Retrospective cohort | 33,330 | Noncardiac surgery | MAP <55 mmHg: AKI OR 1.18 per min; mortality OR 1.036 per min below threshold | Moderate |
| Gregory et al. 2021 | Retrospective multicentre | 316,717 | Noncardiac surgery | Dose-response: cumulative time <MAP thresholds associated with MACCE; absolute > relative thresholds | Moderate |
| Sessler et al. 2018 (POISE-2) | RCT substudy | 9,765 | High-risk noncardiac | Postop hypotension more strongly associated with MI/death than intraop hypotension | High |
| Mathis et al. 2020 | Multi-centre retrospective | 138,021 | Noncardiac surgery | Baseline risk modifies threshold: high-risk patients injured at MAP 55–59; low-risk show no association | Moderate |
| Futier et al. 2017 (INPRESS) | Multicentre RCT | 298 | High-risk major surgery | Individualised MAP target (within 10% baseline) reduced composite organ dysfunction vs standard (MAP ≥80) | High |
| Wanner et al. 2021 | Single-centre RCT | 458 | High CV risk, noncardiac | MAP ≥75 vs ≥60 mmHg: no difference in composite AKI/myocardial injury/MACE | High |
| Saugel et al. 2024 (POQI) | Consensus statement | NR | All surgical patients | Recommend MAP ≥60 mmHg in at-risk patients; higher targets when venous/compartment pressure elevated | High |
| Hatib et al. 2018 (BJS Open MA) | SR/MA of cohort studies | NR | Noncardiac surgery | IOH associated with mortality, AKI, MI, stroke, delirium; severity-outcome dose-response | Moderate |
| Meta-analysis RCTs 2025 (BMC Anesth) | MA of RCTs (2014–2024) | NR | Noncardiac, non-obstetric | Low (<60), moderate (60–75), high (>75) thresholds: no significant difference in composite complications | Moderate |
Key Findings: Intraoperative Hypotension and Organ Injury Thresholds
The Dose-Response Relationship: Depth and Duration Both Matter
The foundational insight from the observational literature is that intraoperative hypotension-related organ injury follows a graded dose-response pattern incorporating both the depth of blood pressure reduction and the duration of exposure. The Salmasi et al. (2017) analysis of 57,315 noncardiac surgical patients established that MAP below absolute thresholds of 65 mmHg or relative thresholds of 20% below baseline were progressively associated with both myocardial injury and acute kidney injury. At any given threshold, prolonged exposure was associated with increased odds of injury. Critically, the study found no interaction between preoperative blood pressure and the intraoperative threshold — meaning that absolute MAP targets can guide management without needing to individualise based on preoperative baseline.
A systematic review by Bijker et al. (2018) synthesised 42 articles and reported a tiered risk framework: prolonged exposure (≥10 min) to MAP <80 mmHg, shorter durations of MAP <70 mmHg, and any exposure to MAP <55 mmHg were each associated with end-organ injury. The largest multicentre cohort study (Gregory et al. 2021, 316,717 patients) confirmed dose-dependent associations between cumulative time below MAP thresholds and a composite of major adverse cardiovascular and cerebrovascular events.
Baseline Risk Modifies the Threshold
A critical refinement came from Mathis et al. (2020), who analysed 138,021 noncardiac surgical cases across 8 hospitals. After stratifying patients into preoperative risk quartiles based on comorbidities and procedure type, they found that the hypotension-AKI relationship was powerfully modified by baseline risk. Low-risk patients showed no association between intraoperative hypotension and AKI at any threshold. Medium-risk patients were vulnerable only to severe hypotension (MAP <50 mmHg, adjusted OR 2.62). Patients in the highest risk quartile developed AKI even at mild hypotension ranges (MAP 55–59 mmHg, adjusted OR 1.34). This finding reframes the threshold question: there is no single “safe” MAP for all patients — the harm threshold varies by preoperative vulnerability.
AKI is the organ injury most consistently linked to intraoperative hypotension, with the largest number of studies and the most robust dose-response data. A 2024 systematic review concluded that MAP below 65 mmHg for more than 5 minutes is strongly associated with postoperative AKI, with risk increasing with both magnitude and duration. The Walsh et al. (2013) cohort found that each minute of MAP <55 mmHg increased AKI odds by 18%. The kidney’s susceptibility reflects its unique physiology: renal autoregulation maintains constant glomerular filtration across a range of perfusion pressures, but this autoregulatory plateau has a lower limit — typically around MAP 60–70 mmHg in healthy adults, potentially higher in patients with chronic hypertension, diabetes, or chronic kidney disease.
The INPRESS trial by Futier et al. (2017) — the most influential interventional study in this field — randomised 298 high-risk patients to individualised MAP management (within 10% of resting baseline) versus standard care (targeting systolic >80 mmHg). The individualised group had significantly lower rates of a composite endpoint that included AKI. This trial provides the closest evidence to causal proof that MAP management can prevent postoperative kidney injury, though the composite endpoint and modest sample size limit definitive conclusions.
Myocardial injury after noncardiac surgery (MINS) is increasingly recognised as a common and prognostically important complication. The POISE-2 substudy by Sessler et al. (2018) provided a key insight: hypotension during and for four days after noncardiac surgery was associated with a composite of myocardial infarction and death, with postoperative hypotension showing a stronger association than intraoperative hypotension. Each clinically significant postoperative hypotensive episode (systolic <90 mmHg) was independently associated with increased 30-day mortality and MI risk.
However, the Wanner et al. (2021) RCT directly tested whether targeting MAP ≥75 mmHg versus ≥60 mmHg in 458 high-cardiovascular-risk patients reduced a composite of myocardial injury, AKI, and major adverse cardiovascular events — and found no difference (48% vs 52%, risk difference −4.2%, 95% CI −13% to 5%). The POQI consensus group noted that this negative result may reflect the relatively modest difference in achieved MAP between groups (median MAP <65 mmHg for 9 vs 23 min), suggesting that both groups avoided severe hypotension, potentially obscuring a real effect.
The relationship between intraoperative hypotension and perioperative stroke is less consistent than for AKI or myocardial injury. A multicentre retrospective study of 316,717 patients found that MAP <55 mmHg was associated with increased postoperative delirium. One RCT of 322 elderly patients reported that targeting MAP 95–100 mmHg during noncardiac surgery reduced postoperative delirium by 50% compared with MAP 60–70 mmHg. However, a pilot trial of 101 patients aged ≥75 years found no effect of personalised versus untargeted MAP management on delirium or cognitive dysfunction at 3 months.
The cerebral autoregulatory range is typically wider than the renal range, and individual variation is substantial — particularly in patients with chronic hypertension, cerebrovascular disease, or carotid stenosis. The POQI consensus noted that intraoperative lower limits of cerebral blood flow autoregulation are poorly characterised and likely differ substantially between patients, making population-level MAP targets less reliable for preventing neurological injury than for preventing AKI.
One of the most important emerging findings is that postoperative hypotension may be more strongly associated with adverse outcomes than intraoperative hypotension — yet it receives far less attention. The POISE-2 substudy demonstrated that the association between hypotension and the composite of MI and death was stronger for postoperative days 1–4 than for the intraoperative period. The VISION cohort confirmed that postoperative hypotension is both common and strongly predictive of major vascular events.
The 2024 POQI consensus statement explicitly stated: “Postoperative hypotension is often unrecognised and might be more important than intraoperative hypotension because it is often prolonged.” Standard ward-based intermittent blood pressure monitoring may miss substantial periods of postoperative hypotension. Continuous monitoring technologies for the postoperative period are available but not widely implemented. One practical recommendation is to delay restarting chronic antihypertensive medications until clearly necessary — a simple intervention that may reduce postoperative hypotensive episodes.
Quality and Consistency of Evidence
What the Evidence Does Not Show
The observational evidence demonstrating an association between intraoperative hypotension and organ injury is robust — but no large, adequately powered RCT has proven that actively maintaining MAP above any specific threshold reduces postoperative AKI, myocardial injury, or mortality. The crucial distinction between association and causation remains unresolved.
Individual autoregulatory thresholds for different organs are poorly characterised intraoperatively. While population-level data converge on MAP ~65 mmHg, the lower limit of renal autoregulation may be substantially higher in patients with chronic hypertension or CKD — and no bedside tool currently identifies this limit in real time. Whether vasopressor-driven blood pressure elevation (which raises MAP without necessarily improving cardiac output or tissue oxygen delivery) confers the same benefit as volume-driven or cardiac-output-optimised pressure maintenance is unknown.
The interaction between intraoperative hypotension and anaemia remains inadequately studied. The “double hit” of low perfusion pressure and reduced oxygen-carrying capacity may create synergistic injury, but threshold data for combined exposure are sparse. Additionally, the role of blood pressure variability (as distinct from absolute hypotension) in organ injury is increasingly recognised but incompletely characterised. Finally, cost-effectiveness analyses comparing different monitoring strategies (intermittent vs continuous, invasive vs non-invasive) and their impact on hypotension prevention and downstream outcomes are needed to guide resource allocation.
Practical Implications
Based on the current evidence, the following considerations apply to surgical and anaesthetic teams managing patients at risk of intraoperative hypotension.
The POQI 2024 consensus recommends MAP ≥60 mmHg in at-risk patients. The converging observational evidence and biological rationale support this as a reasonable floor, particularly for patients with comorbidities that impair autoregulation. In practice, avoiding even brief episodes below MAP 55 mmHg should be prioritised, as any exposure at this level appears harmful.
RCTs show that continuous arterial pressure monitoring detects nearly twice as much hypotension as intermittent oscillometric monitoring, and finger-cuff monitoring reduces time-weighted average hypotension by 2- to 10-fold. For major surgery or high-risk patients, continuous monitoring facilitates earlier intervention and meaningful reduction in hypotensive exposure.
The evidence suggests that postoperative hypotension may be at least as important as intraoperative hypotension for predicting MI and death. Practical steps include delaying restart of chronic antihypertensives until haemodynamic stability is assured, and considering enhanced monitoring in the first 48–72 hours after high-risk procedures.
While observational data suggest harm may begin at MAP <80 mmHg with prolonged exposure, RCTs targeting MAP ≥75 mmHg have not shown improved outcomes versus ≥60 mmHg. This gap between association and intervention means that aggressively pursuing MAP ≥75 mmHg with vasopressors is not yet evidence-based and may carry its own risks (tachycardia, afterload mismatch, splanchnic vasoconstriction).
Evidence Grade and Bottom Line
Overall Evidence Grade: Strong (association) / Limited (interventional proof)
The association between intraoperative hypotension and postoperative organ injury is well established through large observational studies with consistent dose-response relationships. However, the interventional evidence — proving that actively avoiding hypotension prevents organ injury — remains limited to one positive RCT (INPRESS) and one negative RCT (Wanner), with the most recent meta-analysis of RCTs finding no significant difference across blood pressure management thresholds.
- Intraoperative hypotension below MAP 65 mmHg is consistently associated with postoperative AKI, myocardial injury, stroke, and mortality in noncardiac surgery — in a dose-dependent fashion with both depth and duration.
- Baseline patient risk modifies the threshold: high-risk patients are vulnerable to injury at MAP 55–59 mmHg, while low-risk patients may tolerate mild hypotension without measurable harm.
- RCTs comparing higher versus lower MAP targets have produced conflicting results, and no trial has definitively proven that any specific target prevents organ injury.
- Postoperative hypotension may be more strongly associated with adverse outcomes than intraoperative hypotension — and is substantially under-monitored on standard surgical wards.
- The gap between robust observational association and interventional proof represents the most important unresolved question in perioperative haemodynamic management.
Article Information
For Educational Purposes Only. This is an original evidence synthesis informed by the studies listed below. It does not replace clinical judgement. Drug dosages should be verified against current prescribing information.
References
- Salmasi V, Maheshwari K, Yang D, et al. Relationship between Intraoperative Hypotension, Defined by Either Reduction from Baseline or Absolute Thresholds, and Acute Kidney and Myocardial Injury after Noncardiac Surgery. Anesthesiology. 2017;126(1):47–65. DOI: 10.1097/ALN.0000000000001432
- Walsh M, Devereaux PJ, Garg AX, et al. Relationship between Intraoperative Mean Arterial Pressure and Clinical Outcomes after Noncardiac Surgery: Toward an Empirical Definition of Hypotension. Anesthesiology. 2013;119(3):507–515. DOI: 10.1097/ALN.0b013e3182a10e26
- Gregory A, Stapelfeldt WH, Khanna AK, et al. Intraoperative Hypotension Is Associated with Adverse Clinical Outcomes after Noncardiac Surgery. Anesth Analg. 2021;132(6):1654–1665. DOI: 10.1213/ANE.0000000000005250
- Sessler DI, Meyhoff CS, Zimmerman NM, et al. Period-dependent Associations between Hypotension during and for Four Days after Noncardiac Surgery and a Composite of Myocardial Infarction and Death. Anesthesiology. 2018;128(2):317–327. DOI: 10.1097/ALN.0000000000001985
- Mathis MR, Naik BI, Freundlich RE, et al. Preoperative Risk and the Association between Hypotension and Postoperative Acute Kidney Injury. Anesthesiology. 2020;132(3):461–475. DOI: 10.1097/ALN.0000000000003063
- Futier E, Lefrant JY, Guinot PG, et al. Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A Randomized Clinical Trial. JAMA. 2017;318(14):1346–1357. DOI: 10.1001/jama.2017.14172
- Wanner PM, Wulff DU, Djurdjevic M, et al. Targeting Higher Intraoperative Blood Pressures Does Not Reduce Adverse Cardiovascular Events Following Noncardiac Surgery. J Am Coll Cardiol. 2021;78(18):1753–1764. DOI: 10.1016/j.jacc.2021.08.048
- Saugel B, Sessler DI, Gan TJ, et al. PeriOperative Quality Initiative (POQI) International Consensus Statement on Perioperative Arterial Pressure Management. Br J Anaesth. 2024;133(3):426–440. DOI: 10.1016/j.bja.2024.04.040
- Bijker JB, Persoon S, Peelen LM, et al. Intraoperative Hypotension and the Risk of Postoperative Adverse Outcomes: A Systematic Review. Br J Anaesth. 2018;121(4):706–721. DOI: 10.1016/j.bja.2018.04.036
- Penev Y, Ruppert MM, Bilgili A, et al. Intraoperative Hypotension and Postoperative Acute Kidney Injury: A Systematic Review. Am J Surg. 2024;232:45–53. DOI: 10.1016/j.amjsurg.2024.02.001
- de Keijzer IN, Scheeren TWL, et al. Association of Intraoperative Hypotension with Postoperative Morbidity and Mortality: Systematic Review and Meta-analysis. BJS Open. 2021;5(1):zraa018. DOI: 10.1093/bjsopen/zraa018